Immune checkpoint therapy-current perspectives and future directions
Padmanee Sharma1, Sangeeta Goswami2, Deblina Raychaudhuri3
1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cell
|April 14, 2023
Summary
Immune checkpoint therapy (ICT) offers durable cancer benefits but has variable response rates. Understanding immune and non-immune factors is crucial for optimizing patient selection and improving ICT efficacy.
Area of Science:
- Immunology
- Oncology
- Cancer Therapy
Background:
- Immune checkpoint therapy (ICT) has revolutionized cancer treatment, providing durable responses in some patients.
- Variability in ICT response rates across different tumor types necessitates better patient selection strategies.
- Identifying predictive biomarkers is essential to maximize ICT efficacy and minimize treatment-related toxicities.
Purpose of the Study:
- To review the biological mechanisms of anti-tumor immunity influencing response and resistance to ICT.
- To discuss current challenges and ongoing efforts to improve ICT effectiveness.
- To outline strategies for future clinical trials and combination therapies involving ICT.
Main Methods:
- Literature review focusing on anti-tumor immunity.
- Analysis of factors affecting response and resistance to immune checkpoint inhibitors.
- Synthesis of data to inform future clinical development.
Main Results:
- Detailed exploration of immune and non-immune factors impacting ICT outcomes.
- Identification of key challenges hindering broader ICT application.
- Proposed strategies for optimizing patient selection and combination therapies.
Conclusions:
- A comprehensive understanding of anti-tumor immunity is vital for advancing ICT.
- Addressing current limitations requires a multi-faceted approach including biomarker discovery.
- Future research should focus on combinatorial strategies and refined clinical trial designs to enhance ICT benefits.
Related Concept Videos
01:27Tumor Immunotherapy
596
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
596
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:30Cancer Vaccines
456
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
456